galiximab

Related by string. * * *

Related by context. Frequent words. (Click for all words.) 75 elotuzumab 74 pertuzumab 73 mycophenolate mofetil 72 Cloretazine R VNP#M 72 HER2 positive metastatic breast 71 irbesartan 71 Fludara 71 chlorambucil 71 relapsed multiple myeloma 70 tanespimycin 70 nilotinib 70 Amrubicin 70 Epratuzumab 70 KRN# 70 active comparator 69 Azedra 69 ZD# [001] 69 Pivotal Phase III 69 Zolinza 69 carboplatin paclitaxel 69 Bortezomib 69 mRCC 69 fulvestrant 69 nab paclitaxel 69 R sorafenib tablets 69 decitabine 69 relapsed refractory multiple myeloma 69 romidepsin 69 GSK# [001] 69 plus prednisone 69 Taxotere ® 69 PREZISTA r 68 metastatic hormone refractory 68 Phase Ib clinical 68 DOXIL 68 TORISEL 68 Navelbine 68 goserelin 68 glatiramer acetate 68 Bevacizumab 68 Traficet EN 68 PXD# 68 Pegasys ® 68 dasatinib 68 azacitidine 68 plus dexamethasone 68 bleomycin 68 Vandetanib 68 tipranavir 68 Herceptin trastuzumab 68 Metastatic Melanoma 67 dacarbazine 67 IMC A# 67 Imprime PGG 67 Panzem R 67 talabostat 67 tocilizumab 67 pharmacodynamic effects 67 DAVANAT 67 Gemzar ® 67 cabazitaxel 67 deforolimus 67 daunorubicin 67 TYKERB 67 TELCYTA 67 XELOX 67 Natalizumab 67 OncoVEX GM CSF 67 thymalfasin 67 BAY #-# 67 bevacizumab Avastin 67 temsirolimus 67 axitinib 67 low dose dexamethasone 67 HGS ETR1 67 tolvaptan 67 superficial bladder cancer 67 chemoradiotherapy 67 Pharmacokinetic 67 Mylotarg 66 CoFactor 66 Trastuzumab 66 Torisel 66 FOLFIRI 66 selegiline 66 LY# [003] 66 Doxil 66 Targretin 66 placebo controlled clinical 66 vinorelbine 66 adalimumab 66 Erlotinib 66 indolent NHL 66 Hycamtin 66 renal toxicity 66 rHuPH# 66 double blinded placebo 66 Phase 1b trial 66 therapeutic regimens 66 xenograft models 66 CCX#

Back to home page